by Raul Lopez | May 29, 2025 | blog
Updated September 2026. This article is educational and is not medical or legal advice.
This topic attracts two kinds of writing: breathless evangelism and joyless debunking. Both are lazy. There is no legal or medical category called “entheogens” that grants a universal exemption. Safety depends on the substance, person and context; legality depends on jurisdiction, possession, setting, religious claims and sometimes very specific court decisions.
The boring legal detail that matters
Many substances described as entheogens remain federally controlled in the United States. A sharper article does not need to kill the romance. It just refuses to make the romance do the job of evidence.
Where people get tripped up
Religious use can involve narrow legal protections or exemptions, but sincerity and organizational context matter; “my spirituality says yes” is not a universal defense. The story gets better, not worse, when the uncertainties are visible. At least then we know which doors are genuinely still open.
The jurisdiction problem
Different substances carry different physiological and interaction risks, especially when MAO inhibitors, cardiovascular effects or psychiatric vulnerability are involved. If the answer depends heavily on dose, person, place or preparation, then the context is not a footnote. It is part of the phenomenon.
What changed—and what did not
The responsible answer starts by naming the exact substance and place instead of treating “entheogen” as a legal invisibility cloak. That does not make the observation trivial. It makes the claim testable, which is a considerable improvement over incense and certainty.
There is enough here to justify continued attention without pretending the last chapter has already been written. In psychedelic culture, that may qualify as radical restraint.
Where that leaves us
There is enough here to justify attention and not enough to justify evangelism. That middle ground is less marketable, admittedly, but it is also where most serious understanding begins.
This connects naturally with Psychedelics and Mystical Experiences: When the Ineffable Meets a Questionnaire.
Where the science ends and the art starts
The science does not become stronger because there is art about it. The art does, however, show how these ideas escape the laboratory and enter culture. Browse Meditation & spirituality art, the psychedelic art posters collection, or see Meditating With Psychedelics T-shirt.
Sources and further reading
by Raul Lopez | Nov 15, 2024 | blog
Updated September 2026. This article is educational and is not medical or legal advice.
The subject is stranger than the headline and usually less magical than the marketing. Ibogaine has one of the most dramatic reputations in addiction treatment: reports of rapid withdrawal relief alongside a documented risk of dangerous cardiac arrhythmias. The evidence is intriguing, heterogeneous and nowhere near a license to treat it as an underground miracle cure.
What patients in trials actually received
Observational studies report reductions in withdrawal and craving, but randomized controlled evidence for opioid use disorder remains limited. One study can move a question forward without settling it. Psychedelic headlines occasionally struggle with this modest concept.
The comparison group problem
Ibogaine and its metabolite can prolong the QT interval and have been associated with ventricular arrhythmias and deaths. The real signal is easier to see once “promising,” “proven” and “possible” stop being treated as synonyms.
How strong is the signal?
Standard medications for opioid use disorder such as buprenorphine and methadone have strong mortality-reduction evidence and should not be dismissed as spiritually inferior. Interest survives uncertainty just fine. In fact, most of the genuinely interesting questions begin after the certainty has been removed.
Where this leaves the field
Research into ibogaine, noribogaine and analogues may produce safer options, but the cardiac problem is not a footnote—it is central to the benefit-risk question. Treating a hypothesis as a hypothesis is not cynicism. It is how you keep an interesting idea alive long enough to find out whether it is true.
That is the version worth keeping: specific enough to be challenged, flexible enough to absorb new evidence and weird enough that nobody needs to manufacture extra mystery.
The useful uncertainty
Uncertainty is not a failure state. It is information. Knowing exactly where the evidence thins out is often more valuable than another confident paragraph pretending the map continues past the edge.
If this raised another question, try The Ethics of Psychedelic Research: Consent, Hype, Power and Who Gets Left Out.
Where the science ends and the art starts
The science does not become stronger because there is art about it. The art does, however, show how these ideas escape the laboratory and enter culture. Browse Psychonaut art & clothing, the psychedelic T-shirts collection, or see Psychedelic Research Volunteer T-shirt.
Sources and further reading
by Raul Lopez | Nov 14, 2024 | blog
Updated September 2026. This article is educational and is not medical or legal advice.
Psychedelic culture has a talent for turning an interesting observation into a religion by Tuesday. Ayahuasca and psilocybin can both produce profound alterations in perception and self-experience, but they are not interchangeable plant versions of the same drug. Their chemistry, duration, cultural context and interaction profiles differ substantially.
Where the story gets exaggerated
Psilocybin is converted to psilocin; ayahuasca traditionally combines DMT-containing plant material with beta-carbolines that inhibit monoamine oxidase. Treating a hypothesis as a hypothesis is not cynicism. It is how you keep an interesting idea alive long enough to find out whether it is true.
Why mechanism is not outcome
MAO inhibition creates clinically important interaction concerns that are not equivalent to those of psilocybin. That is a narrower claim than the mythology usually offers, but narrower claims have the useful habit of being checkable.
What would actually change our minds
Ayahuasca is embedded in multiple Amazonian and religious traditions, while modern psilocybin use has different historical pathways. A useful explanation should survive contact with the awkward details, including the details that refuse to fit the preferred narrative.
What we actually know
Comparing which is “stronger” is less useful than comparing pharmacology, setting, duration, screening and the kind of experience being discussed. Sometimes the most useful answer is “we do not know yet,” provided we are precise about what is already known around the edges.
The important thing is to keep the layers separate: pharmacology, personal report, cultural interpretation and commercial mythology. They interact constantly, but they are not interchangeable forms of evidence.
A less mystical conclusion
Psychedelic subjects do not need inflated claims to be strange, culturally important or worth studying. The evidence is allowed to be incomplete. The art, history and human behavior around it are interesting enough without borrowing certainty from the future.
Another piece in the same orbit is Ayahuasca Ceremonies: What to Expect, What to Question and What Not to Romanticize.
The studio version of the idea
Consider this the hard border between information and merchandise. On the other side: artwork inspired by the topic, with no therapeutic claims attached. Browse Ayahuasca-inspired art & apparel, the psychedelic journals and notebooks collection, or see Mother Ayahuasca journal.
Sources and further reading
by Raul Lopez | Nov 12, 2024 | blog
Updated September 2026. This article is educational and is not medical or legal advice.
Here is the useful version, without the incense-cloud certainty: Some of the most humane psychedelic research asks a narrow question: can a supported psychedelic experience reduce depression, anxiety or existential distress in people facing serious illness? Early studies are encouraging, but compassion is not permission to overstate the evidence.
What clinicians still need to know
Small trials in patients with life-threatening illness have reported durable reductions in anxiety and depressive symptoms after supported psilocybin sessions. The story gets better, not worse, when the uncertainties are visible. At least then we know which doors are genuinely still open.
What the evidence says
The target is usually distress and quality of life, not treatment of the underlying cancer or terminal disease. If the answer depends heavily on dose, person, place or preparation, then the context is not a footnote. It is part of the phenomenon.
The gap between a trial and a treatment
Medical fragility, medications, prognosis and consent make this population different from healthy volunteers at a retreat. That does not make the observation trivial. It makes the claim testable, which is a considerable improvement over incense and certainty.
Where benefit meets uncertainty
Meaning-centered care, family support, palliative medicine and psychiatric treatment remain important whether or not psychedelic therapy becomes more available. This matters because psychedelic culture has a long and occasionally magnificent tradition of turning “possibly” into “obviously.”
Taken as a whole, the evidence supports curiosity more comfortably than certainty. That is not a disappointing conclusion; it is a useful one, especially in a field where enthusiasm routinely outruns the sample size.
What to carry forward
If there is a thread worth carrying forward, it is curiosity with brakes. Ask better questions, demand better evidence, and allow the cultural meaning of psychedelics to remain richer than a clinical claim or a marketing line.
Continue the thread with Ibogaine and Opioid Addiction: Why the Hope Comes With Serious Risk.
The cultural afterimage
No capsules, protocols or miracle claims here—just the visual afterlife of the idea in PsychonautDream artwork. Browse Meditation & spirituality art, the psychedelic art posters collection, or see Meditating With Psychedelics T-shirt.
Sources and further reading
by Raul Lopez | Nov 11, 2024 | blog
Updated September 2026. This article is educational and is not medical or legal advice.
Virtual reality can manipulate environment, attention and exposure with extraordinary precision. Psychedelic therapy is unusually sensitive to environment. Combining them is therefore scientifically plausible—and a perfect setup for tech hype to arrive twelve minutes early.
What follow-up tells us
VR can deliver controlled environments, guided relaxation, exposure scenarios or nature simulations before or after psychedelic sessions. This matters because psychedelic culture has a long and occasionally magnificent tradition of turning “possibly” into “obviously.”
Why setting is part of the intervention
Using immersive technology during an acute psychedelic state raises practical questions about sensory overload, agency and what the device is actually improving. There are real questions here. They become easier to see once the promotional fog and psychedelic folklore are moved out of the way.
Risk, screening and context
Small feasibility projects are interesting but do not establish that VR adds benefit beyond thoughtful rooms, music and human support. The strongest version of the idea is usually the one that needs the fewest miracles to stay standing.
Who gets screened out matters
The best use may turn out to be preparation or integration rather than replacing reality at the exact moment reality is already having a difficult day. There is a difference between respecting an experience and accepting every explanation attached to it. We can manage both.
None of this requires treating psychedelic experience as trivial. It requires the opposite: taking it seriously enough not to decorate weak claims until they look strong.
So what survives the trip?
The useful version of this subject is the one that still makes sense after the adjectives come off. Keep what is documented, label what is interpretation, and leave the genuinely open questions open. They are usually the most interesting part anyway.
The cluster continues in Psychedelics in End-of-Life and Palliative Care: Meaning When Time Is Short.
Where the science ends and the art starts
PsychonautDream is an art project, not a clinic, pharmacy or legal service. If you came for the visual culture rather than a treatment protocol, the related collections are a safer place to wander. Browse Visionary dreamscapes, the psychedelic art posters collection, or see The Psychonaut poster.
Sources and further reading
by Raul Lopez | Nov 9, 2024 | blog
The subject is stranger than the headline and usually less magical than the marketing. Integration is the unfashionable part of psychedelic culture where the cosmic download has to survive Tuesday. It means making sense of an experience, testing its interpretations and translating anything useful into behavior rather than collecting revelations like Pokémon.
The cultural residue
Integration can involve reflection, therapy, journaling, community or practical changes; there is no single standardized method. There is a difference between respecting an experience and accepting every explanation attached to it. We can manage both.
The version worth rescuing
Not every intense belief deserves implementation, especially when sleep loss, mania, paranoia or grandiosity are present. Anecdotes can point toward a question, but they cannot do the statistical heavy lifting simply because the anecdote is spectacular.
What the poster on the wall is really saying
Clinical programs often build preparation and follow-up into treatment because the acute session is only one part of the intervention. The sensible version leaves enough room for both fascination and the possibility that the first explanation is wrong.
How the story became bigger than the fact
The strongest integration question is painfully ordinary: what changed in your actual life? A dramatic mechanism is still only a mechanism; it does not automatically prove a benefit, a risk or a cosmic interpretation.
What matters most is proportion. Big experiences do not automatically justify big claims, and small studies do not become useless merely because they cannot answer everything.
Keep the weird, lose the nonsense
Skepticism is not the enemy of psychedelic culture; bad certainty is. The better approach is to keep the curiosity, keep the difficult questions and stop asking a beautiful story to impersonate a settled fact.
The next useful comparison is What Are Entheogens? The Word, the Drugs and the Cultural Baggage.
The artwork that grew out of it
PsychonautDream exists partly because certain ideas refuse to remain text for very long. Browse Psychonaut art & clothing, the psychedelic journals and notebooks collection, or see The Psychonaut poster.